This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Normal University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ziqiang Bai: Innovator in Anti-Tumor Drug Development
Introduction
Ziqiang Bai is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-tumor drugs. His innovative work has led to the creation of a unique nitric oxide donor derivative that holds promise for cancer treatment.
Latest Patents
Ziqiang Bai holds a patent for a "14-chloro-β-elemene nitric oxide donor derivative and preparation method and use thereof." This patent discloses a method for preparing a nitric oxide donor derivative that can be utilized in the formulation of anti-tumor drugs. The compound features a general formula where R represents a linear or cyclic alcohol amine structure containing nitrogen and oxygen atoms. Each of R and R is independently selected from various groups, including Calkyl, Ccycloalkyl, Caryl, 5- to 10-membered cyclic heteroaryl, Calkenyl, Calkynyl, and Calkoxy. This innovation is a testament to his expertise and dedication to advancing cancer therapies.
Career Highlights
Ziqiang Bai is affiliated with Hangzhou Normal University, where he continues to engage in research and development. His academic background and ongoing work contribute to the advancement of scientific knowledge in his field. With a focus on practical applications, he aims to translate his research into effective treatments for patients.
Collaborations
Ziqiang Bai has collaborated with notable colleagues, including Tian Xie and Renren Bai. These partnerships enhance the research environment and foster innovation in their shared pursuits.
Conclusion
Ziqiang Bai's contributions to the field of anti-tumor drug development exemplify the impact of innovative thinking in medicine. His patent for the 14-chloro-β-elemene nitric oxide donor derivative represents a significant step forward in cancer treatment. Through his work at Hangzhou Normal University and collaborations with fellow researchers, he continues to push the boundaries of scientific discovery.